Some feel like theyre missing out on something everyone else is doing
They're marketed as being cheaper, easier to use, and available to anyone, unlike prescription weight loss injections, which require a consultation and have specific eligibility criteria
Diabetes (2011) 60:191725
The ADVANCE Collaborative Group
Retatrutide is an investigational triple incretin receptor agonist activating GLP-1, GIP, and glucagon receptors that remains unlicensed in the UK as of mid-2025
After week four, we tend to increase the dose to try to achieve more weight loss. How much weight you lose varies based on a few factors, including your biology and any lifestyle changes youre making